Prognostic Impact of Delta-haemolysin Production Deficiency in Staphylococcus Aureus on the Prognosis of Infected Implant Treated by DAIR

Civil Hospices of Lyon

Status: Enrolling

Conditions: Bone and Joint Infection; Staphylococcus Aureus

Treatments: Other: Delta-haemolysin

Study type: Observational

Funder types: Other

Identifiers

NCT03796104

18-333

Details and patient eligibility

About

The aim of this study is to determine if delta-haemolysin production deficiency of Staphylococcus aureus is a marker in favour of chronic infections on implants

Enrollment: 100 estimated patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients having implant infection due to S. aureus treated by DAIR

Exclusion criteria

• none

Trial design

100 participants in 2 patient groups

Deficiency of delta-hemolysine

Description:

Implant infected by Staphylococcus aureus with delta-haemolysin Production Deficiency

Treatment:

Other: Delta-haemolysin

Presence of delta-hemolysine

Description:

Implant infected by Staphylococcus aureus with delta-haemolysin Production

Treatment:

Other: Delta-haemolysin